Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 5
2005 11
2006 3
2007 5
2008 15
2009 9
2010 16
2011 12
2012 14
2013 12
2014 15
2015 25
2016 21
2017 19
2018 17
2019 18
2020 21
2021 36
2022 30
2023 39
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Brzdęk M, Zarębska-Michaluk D, Tomasiewicz K, Tudrujek-Zdunek M, Lorenc B, Mazur W, Berak H, Janocha-Litwin J, Klapaczyński J, Sitko M, Janczewska E, Dybowska D, Parfieniuk-Kowerda A, Piekarska A, Jaroszewicz J, Flisiak R. Brzdęk M, et al. Among authors: flisiak r. Minerva Med. 2024 Apr 9. doi: 10.23736/S0026-4806.24.09238-3. Online ahead of print. Minerva Med. 2024. PMID: 38591836
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
Dobrowolska K, Pawłowska M, Zarębska-Michaluk D, Rzymski P, Janczewska E, Tudrujek-Zdunek M, Berak H, Mazur W, Klapaczyński J, Lorenc B, Janocha-Litwin J, Parfieniuk-Kowerda A, Dybowska D, Piekarska A, Krygier R, Dobracka B, Jaroszewicz J, Flisiak R. Dobrowolska K, et al. Among authors: flisiak r. J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13936. Online ahead of print. J Viral Hepat. 2024. PMID: 38483035
Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapy.
Zarębska-Michaluk D, Brzdęk M, Rzymski P, Dobrowolska K, Flisiak R. Zarębska-Michaluk D, et al. Among authors: flisiak r. Pol Arch Intern Med. 2024 Jan 29;134(1):16638. doi: 10.20452/pamw.16638. Epub 2024 Jan 2. Pol Arch Intern Med. 2024. PMID: 38164525 Free article.
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review.
Kasianchuk N, Dobrowolska K, Harkava S, Bretcan A, Zarębska-Michaluk D, Jaroszewicz J, Flisiak R, Rzymski P. Kasianchuk N, et al. Among authors: flisiak r. Viruses. 2023 Dec 8;15(12):2395. doi: 10.3390/v15122395. Viruses. 2023. PMID: 38140636 Free PMC article. Review.
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
Zarębska-Michaluk D, Flisiak R, Janczewska E, Berak H, Mazur W, Janocha-Litwin J, Krygier R, Dobracka B, Jaroszewicz J, Parfieniuk-Kowerda A, Dobrowolska K, Rzymski P. Zarębska-Michaluk D, et al. Among authors: flisiak r. Antiviral Res. 2023 Dec;220:105742. doi: 10.1016/j.antiviral.2023.105742. Epub 2023 Nov 7. Antiviral Res. 2023. PMID: 37944825 Free article.
327 results